Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Hosenkol B-3-O-β-D-glucopyranosyl（2-1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
Hosenkol B-3-O-β-D-glucopyranosyl（2-1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
CAS No. ———
Hosenkol B-3-O-β-D-glucopyranosyl（2-1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside( ——— )
Catalog No. M38428 CAS No. ———
Hosenkol B-3-O-β-D-glucopyranosyl（2→1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHosenkol B-3-O-β-D-glucopyranosyl（2-1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionHosenkol B-3-O-β-D-glucopyranosyl（2→1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
-
DescriptionHosenkol B-3-O-β-D-glucopyranosyl（2→1）-β-D-glucopypyranosyl-28-O-β-D-glucopyranoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dehydrotrametenolic ...
Dehydrotrametenolic acid can be a potential anticancer agent against H-ras transformed tumor.
-
Ethyl glucoside
Ethyl glucoside (β-D-Glucopyranoside, ethyl), a shale inhibitor for water-based drilling fluids, is a versatile initiator of enzyme-catalyzed regioselective lactone ring-opening polymerization and is a natural compound found in Sisyrinchium palmifolium.
-
Lixisenatide acetate
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
